Inventor
AARON KEN SATO
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides35%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C12NMicroorganisms or enzymes6%
C12YEnzymes6%
PatentTitleYear
12,297,278Wnt surrogate molecules and uses thereof202512,006,368Anti-frizzled antibodies and methods of use202411,958,891Tissue-specific Wnt signal enhancing molecules and uses thereof202411,773,171WNT surrogate molecules and uses thereof202311,746,150Anti-LRP5/6 antibodies and methods of use202311,512,128VEGF/DLL4 binding agents and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to MEREO BIOPHARMA 5 INC (1)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to SURROZEN OPERATING INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SURROZEN OPERATING INC | 5 | 2023–2025 |
| MEREO BIOPHARMA 5 INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |